TYPE 2 DIABETIC NEPHROPATHY WITH ELEVATED BLOOD LEAD BURDEN

Clinical trials for TYPE 2 DIABETIC NEPHROPATHY WITH ELEVATED BLOOD LEAD BURDEN explained in plain language.

Never miss a new study

Get alerted when new TYPE 2 DIABETIC NEPHROPATHY WITH ELEVATED BLOOD LEAD BURDEN trials appear

Sign up with your email to follow new studies for TYPE 2 DIABETIC NEPHROPATHY WITH ELEVATED BLOOD LEAD BURDEN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could removing lead protect kidneys in diabetes?

Disease control Not yet recruiting

This study tests whether an oral medication that removes lead from the body can slow kidney function decline in people with type 2 diabetes and high lead levels. Participants take dimercaptosuccinic acid (DMSA) capsules for up to 3 months, then are followed for 12 months. The goa…

Matched conditions: TYPE 2 DIABETIC NEPHROPATHY WITH ELEVATED BLOOD LEAD BURDEN

Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

TYPE 2 DIABETIC NEPHROPATHY WITH ELEVATED BLOOD LEAD BURDEN

Get alerted when new TYPE 2 DIABETIC NEPHROPATHY WITH ELEVATED BLOOD LEAD BURDEN trials appear

Could removing lead protect kidneys in diabetes?